Aurinia Pharmaceuticals: Of This Report, Including Exhibit 99.1 Attached Hereto, Is Furnished Pursuant To Item 7.01 Of Form 8k And Shall Not Be Deemed “filed” For Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended, Or Subject To The Liabilities Of That Section. The Information Shall Not Be Deemed Incorporated By Reference Into Any Other Filing With The Sec Made By Aurinia Regardless Of Any General Incorporation Language In Such Filing, Except As Set Forth By Specific Reference In Such Filing, Financial Statements And Exhibits

Mostra articolo completo

Questa funzionalità è disponibile solo per gli utenti registrati

• Nome completo dell'emittente
  Aurinia Pharmaceuticals Inc
• Paese di registrazione
  Canada
• Settore industriale
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***